Retinal pigment epithelial tear following intravitreal bevacizumab for choroidal neovascular membrane due to age-related macular degeneration.
Hannan
Shabeeba R
SR
Madhusudhana
Krishnappa C
KC
Lotery
Andrew J
AJ
Newsom
Richard S B
RS
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D006801:Humans; D008268:Macular Degeneration / Q000150:complications*; D008297:Male; D010857:Pigment Epithelium of Eye / Q000187:drug effects*; D012167:Retinal Perforations / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab